Dyax Corp. Announces First Quarter 2013 Financial Results

Published: Apr 26, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dyax Corp. (NASDAQ: DYAX) today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide) business, the broader angioedema portfolio and the Licensing and Funded Research Program (LFRP).

Help employers find you! Check out all the jobs and post your resume.

Back to news